Vasectomy and risk of prostate cancer.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 12069674)

Published in JAMA on June 19, 2002

Authors

Brian Cox1, Mary J Sneyd, Charlotte Paul, Brett Delahunt, David C G Skegg

Author Affiliations

1: Hugh Adam Cancer Epidemiology Unit, Department of Preventive and Social Medicine, University of Otago Medical School, PO Box 913, Dunedin, New Zealand. brian.cox@stonebow.otago.ac.nz

Articles by these authors

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol (2008) 6.20

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol (2013) 3.68

Prostate cancer screening--finding the middle road forward. N Z Med J (2005) 3.38

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol (2016) 2.94

Revised status of PSA testing in the early detection and treatment of prostate cancer. N Z Med J (2011) 2.54

Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry (2011) 2.53

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. Lancet Oncol (2012) 2.19

Uncommon and recently described renal carcinomas. Mod Pathol (2009) 2.13

Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3. Aust N Z J Obstet Gynaecol (2010) 2.09

Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases. Histopathology (2013) 2.00

Prostate specific antigen testing: age-related interpretation in early prostate cancer detection. Pathology (2013) 1.98

Sexual orientation and self-harm in men and women. Am J Psychiatry (2003) 1.76

Core group evolution over time: high-risk sexual behavior in a birth cohort between sexual debut and age 26. Sex Transm Dis (2003) 1.72

Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf (2003) 1.66

Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res (2005) 1.63

Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res (2002) 1.54

Circumcision and risk of sexually transmitted infections in a birth cohort. J Pediatr (2007) 1.53

Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology (2013) 1.53

Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension. Hum Pathol (2009) 1.51

Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol (2006) 1.50

Redox status of acute pancreatitis as measured by cyclic voltammetry: initial rodent studies to assess disease severity. Crit Care Med (2008) 1.39

Childhood behavior problems linked to sexual risk taking in young adulthood: a birth cohort study. J Am Acad Child Adolesc Psychiatry (2007) 1.37

Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Pathology (2012) 1.29

Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol (2006) 1.22

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol (2010) 1.22

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol (2010) 1.22

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation. Arch Pathol Lab Med (2014) 1.17

Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol (2013) 1.17

Evaluation of explicit prioritisation for elective surgery: a prospective study. J Health Serv Res Policy (2002) 1.17

Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol (2010) 1.16

Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol (2013) 1.15

Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology (2011) 1.14

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol (2010) 1.12

Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol (2007) 1.12

Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol (2006) 1.11

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol (2010) 1.09

Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol (2014) 1.08

Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol (2009) 1.07

The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites. Infect Immun (2010) 1.07

Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis. Mod Pathol (2002) 1.07

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol (2010) 1.07

Child sexual abuse and persistence of risky sexual behaviors and negative sexual outcomes over adulthood: findings from a birth cohort. Child Abuse Negl (2009) 1.06

Same-sex attraction in a birth cohort: prevalence and persistence in early adulthood. Soc Sci Med (2003) 1.05

Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn (2002) 1.04

Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol (2005) 1.03

Parameters of perineural invasion in radical prostatectomy specimens lack prognostic significance. Mod Pathol (2008) 1.02

A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial. Int J Radiat Oncol Biol Phys (2010) 0.97

Changes in the mesenteric lymph proteome induced by hemorrhagic shock. Shock (2010) 0.97

Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. Am J Surg Pathol (2010) 0.97

Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur J Immunol (2008) 0.97

Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives. Anticancer Res (2004) 0.95

Male circumcision and serologically determined human papillomavirus infection in a birth cohort. Cancer Epidemiol Biomarkers Prev (2009) 0.94

Allergen-specific CTL require perforin expression to suppress allergic airway inflammation. J Immunol (2012) 0.93

Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying concept. Anticancer Res (2010) 0.91

Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol (2006) 0.90

The proteome of mesenteric lymph during acute pancreatitis and implications for treatment. JOP (2009) 0.90

Patterns of sexual partnering and reproductive history: associations with timing of first birth in a birth cohort. Perspect Sex Reprod Health (2012) 0.88

Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol (2014) 0.87

Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med (2010) 0.87

Bias in breast cancer research in the screening era. Breast (2013) 0.86

Chromosome 14q LOH in localized clear cell renal cell carcinoma. J Pathol (2002) 0.86

Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study. BMC Public Health (2007) 0.86

What is the middle position on screening? N Z Med J (2005) 0.85

The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer. Pathology (2015) 0.85

International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens: rationale and organization. Mod Pathol (2010) 0.85

Drug safety awareness in New Zealand: public knowledge and preferred sources for information. J Prim Health Care (2012) 0.84

Air travel and fatal pulmonary embolism. Thromb Haemost (2006) 0.84

Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer. Radiother Oncol (2012) 0.84

Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice. Tuberculosis (Edinb) (2012) 0.84

Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology. J Clin Pathol (2011) 0.83

Risk factors for prostate cancer: A national case-control study. Int J Cancer (2006) 0.83

Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology (2010) 0.83

Public good, personal privacy: a citizens' deliberation about using medical information for pharmacoepidemiological research. J Epidemiol Community Health (2009) 0.83

Renal dysplasia produced by obstructive uropathy in the fetal lamb. Pathology (2003) 0.83

HSV-2 incidence by sex over four age periods to age 38 in a birth cohort. Sex Transm Infect (2013) 0.82

Perceived "out of control" sexual behavior in a cohort of young adults from the Dunedin Multidisciplinary Health and Development Study. Arch Sex Behav (2009) 0.82

Prostate cancer--are ethnic minorities disadvantaged? Anticancer Res (2009) 0.82

Biomarkers in renal cancer. Virchows Arch (2014) 0.82

Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration. Pathology (2010) 0.82

Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Am J Clin Pathol (2010) 0.82

Testicular lipomatosis in Cowden's syndrome. Mod Pathol (2005) 0.82

Warming and humidification have no effect on oxidative stress during pneumoperitoneum in rats. Minim Invasive Ther Allied Technol (2011) 0.82

High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. J Clin Endocrinol Metab (2002) 0.81

Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists. Histopathology (2014) 0.81

Obstacles to researching the researchers: a case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials. Trials (2010) 0.81

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Arch (2014) 0.81

School milk and risk of colorectal cancer: a national case-control study. Am J Epidemiol (2011) 0.80

Body piercing, personality, and sexual behavior. Arch Sex Behav (2006) 0.80

Do different types of financial support after illness or injury affect socio-economic outcomes? A natural experiment in New Zealand. Soc Sci Med (2013) 0.80

Traumatic and non-traumatic spinal cord impairment in New Zealand: incidence and characteristics of people admitted to spinal units. Inj Prev (2012) 0.80

Stability and change in same-sex attraction, experience, and identity by sex and age in a New Zealand birth cohort. Arch Sex Behav (2013) 0.80

Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer. BJU Int (2014) 0.80

Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2. Int Immunol (2002) 0.80

Prostate cancer: the new evidence base for diagnosis and treatment. Pathology (2007) 0.80